Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,430,947
-$1,057,990 QoQ
Shares Held
13,421
-11.8% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#312
of 663 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Investment Management Corp of Ontario holds $37,554,611 across 7 Biotechnology names. INSM ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
46,155 | $13,894,039 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,215 | $8,054,476 | |
| 3 | INCY |
Incyte Corp
|
53,029 | $6,011,367 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,642 | $4,765,092 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,300 | $1,928,984 | |
| 6 | RPRX |
Royalty Pharma plc
|
26,212 | $1,469,706 | |
| 7 | INSM |
INSMED Inc
This page
|
13,421 | $1,430,947 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,430,947 | 13,421 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,488,937 | 15,221 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,475,022 | 14,221 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||